estimation of biomarkers araound immediate implant placed with socket shield technique (SST) and Conventional Technique (CT) over a period of 6 month.

Evaluation of Osteocalcin and Metalloproteinase 8 levels in the perimplant crevicular fluid (PICF) around immediate dental implant placed with socket shielding technique (SST) and conventional technique (CT) in maxillary anterior region- A randomized controlled pilot study

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/03/041119

Enrollment

Registered

2022-03-15

Start date

Unknown

Completion date

Unknown

Last updated

2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Immediate Implant placement with Socket Shield Technique.: SST the tooth will be decoronated till the gingival level. Lindemann (long shank) bur will be used to section the tooth and l

Eligibility

Inclusion criteria

Inclusion criteria: Patients in the age between 18-45 years irrespective of gender. Patients having any compromised maxillary anterior tooth/teeth. Patients having intact buccal periodontal tissues. Patients with thick or thin gingival biotype Good oral hygiene and periodontal status of remaining dentition. Non-smoker. With positive informed consent

Exclusion criteria

Exclusion criteria: Metabolic or systemic disease interfere with normal healing Teeth with vertical root fractures on the buccal aspect. Teeth with horizontal root fractures at/below bone level. History of irradiation in the head or neck area. Pregnant or lactating women. Para functional habits Poor oral hygiene and motivation. Psychiatric disorders or unrealistic expectations. Acute infection (abscess) at the site intended for implant placement. Insertion torque during implant placement

Design outcomes

Primary

Measure	Time frame
To evaluate the OCN and MMP 8 levels in PICF around immediate implants placed with SST and CT in the maxillary anterior region at 2 weeks, 3 months, and 6 months.Timepoint: To evaluate the OCN and MMP 8 levels in PICF around immediate implants placed with SST and CT in the maxillary anterior region at 2 weeks, 3 months, and 6 months.	—

Secondary

Measure	Time frame
2. To compare the OCN and MMP 8 levels in PICF around immediate implants placed with SST and CT in the maxillary anterior region at 2 weeks, 3 months, and 6 months.Timepoint: 2 weeks, 3 months, and 6 months.;3. To evaluate and compare the ISQ (implant stability quotient) value of immediate implants placed with SST and CT in the maxillary anterior region at 2 weeks, 3 months, and 6 months.Timepoint: 2 weeks, 3 months, and 6 months.	—

Measure

Time frame

2. To compare the OCN and MMP 8 levels in PICF around immediate implants placed with SST and CT in the maxillary anterior region at 2 weeks, 3 months, and 6 months.Timepoint: 2 weeks, 3 months, and 6 months.;3. To evaluate and compare the ISQ (implant stability quotient) value of immediate implants placed with SST and CT in the maxillary anterior region at 2 weeks, 3 months, and 6 months.Timepoint: 2 weeks, 3 months, and 6 months.

—

Countries

India

Contacts

Public ContactDheeraj Kumar Koli

All India Institute Of Medical Sciences

dr.dheerajkoli@gmail.com9958661988

Outcome results